Evaxion Historical Income Statement
| EVAX Stock | USD 1.19 0.11 8.46% |
Historical analysis of Evaxion Biotech income statement accounts such as Interest Expense of 1 M or Selling General Administrative of 6.4 M can show how well Evaxion Biotech AS performed in making a profits. Evaluating Evaxion Biotech income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Evaxion Biotech's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Evaxion Biotech AS latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Evaxion Biotech AS is a good buy for the upcoming year.
Evaxion |
About Evaxion Income Statement Analysis
Evaxion Biotech AS Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Evaxion Biotech shareholders. The income statement also shows Evaxion investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Evaxion Biotech Income Statement Chart
Add Fundamental
Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Evaxion Biotech AS. It is also known as Evaxion Biotech overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Evaxion Biotech's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Evaxion Biotech AS current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evaxion Biotech AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At this time, Evaxion Biotech's Interest Expense is fairly stable compared to the past year. Research Development is likely to rise to about 13.1 M in 2024, whereas Tax Provision is likely to drop (825.3 K) in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 343.5K | 571.3K | 615.9K | 330.1K | Interest Income | 2.0M | 2.8M | 2.3M | 1.4M |
Evaxion Biotech income statement Correlations
Click cells to compare fundamentals
Evaxion Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Evaxion Biotech income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | (825K) | (1.6M) | (178K) | (772K) | (786K) | (825.3K) | |
| Net Interest Income | (1.2M) | (7K) | 1.1M | 1.3M | (3.0M) | (2.9M) | |
| Interest Income | 9K | 216K | 2.0M | 2.8M | 2.3M | 1.4M | |
| Depreciation And Amortization | 90K | 105.7K | 343.5K | 571.3K | 615.9K | 330.1K | |
| Interest Expense | 1.2M | 223K | 915K | 1.5M | 897K | 1.0M | |
| Selling General Administrative | 2.6M | 5.7M | 6.3M | 8.2M | 10.4M | 6.4M | |
| Other Operating Expenses | 10.9M | 16.6M | 25.8M | 25.3M | 22.3M | 19.5M | |
| Operating Income | (10.9M) | (16.6M) | (25.8M) | (25.3M) | (22.2M) | (23.3M) | |
| Net Income From Continuing Ops | (11.2M) | (15.0M) | (24.5M) | (23.2M) | (24.5M) | (25.7M) | |
| Ebit | (10.9M) | (16.6M) | (24.5M) | (23.2M) | (22.0M) | (23.1M) | |
| Research Development | 8.2M | 10.9M | 19.6M | 17.1M | 11.9M | 13.1M | |
| Ebitda | (10.8M) | (16.5M) | (24.2M) | (22.6M) | (21.4M) | (22.5M) | |
| Total Operating Expenses | 10.9M | 16.6M | 25.8M | 25.3M | 22.2M | 19.5M | |
| Reconciled Depreciation | 81K | 105K | 344K | 571K | 615K | 328.2K | |
| Income Before Tax | (12.0M) | (16.6M) | (24.7M) | (23.9M) | (22.9M) | (24.1M) | |
| Total Other Income Expense Net | (1.2M) | (7K) | 1.1M | 1.3M | (718K) | (682.1K) | |
| Net Income | (11.2M) | (15.0M) | (24.5M) | (23.2M) | (22.1M) | (23.2M) | |
| Income Tax Expense | (825K) | (1.6M) | (178K) | (772K) | (791.2K) | (830.8K) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Evaxion Stock Analysis
When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.